Related Experiment Videos
A rare pancreatic pseudoaneurysm in patient with acute pancreatitis and multiple myeloma
Giovanni Li Destri1, Vanessa Innao, Giuseppe Petrillo
1Department of Surgical Sciences, Organ Transplantation and Advanced Technologies, University of Catania, Catania, Italy. g.lidestri@unict.it
Abstract:
The authors report the case of a 78-year old patient affected by multiple myeloma who develops acute pancreatitis and pseudoaneurysmal dilatation of the inferior pancreaticoduodenal artery causing erosion of the second portion of the duodenal wall and hematemesis. The authors focus first on the supposed etiological relationship between multiple myeloma and acute pancreatitis, and they assume that the therapeutic treatment for the bone marrow disease (bortezomib) may have triggered the pancreatic inflammatory response. They then analyze the pathogenesis of the vascular complication which seems to be related to the lytic action of pancreatic enzymes on the vessel wall which results in the formation of a pseudoaneurysm first and a pseudocyst then. The vascular complication was diagnosed by computed tomography (CT) thus avoiding selective angiography which was considered too invasive for the patient. The careful and conservative treatment of the complication has allowed for full healing of the cephalopancreatic region, in addition to avoiding surgery or embolization treatment of the pseudoaneurysm which is accompanied by a mortality rate as high as 50%.
Insights
Multiple myeloma treatment may trigger acute pancreatitis. A patient developed pancreatitis and a pseudoaneurysm, successfully treated conservatively without invasive procedures.
Area of Science:
- Gastroenterology and Hepatology
- Hematology
- Vascular Surgery
Background:
- Multiple myeloma is a hematologic malignancy.
- Acute pancreatitis is a potential complication.
- Vascular complications, such as pseudoaneurysms, can arise from pancreatitis.
Observation:
- A 78-year-old patient with multiple myeloma developed acute pancreatitis.
- The pancreatitis led to pseudoaneurysmal dilatation of the inferior pancreaticoduodenal artery.
- This pseudoaneurysm eroded the duodenum, causing hematemesis.
Findings:
- Bortezomib, a treatment for multiple myeloma, is hypothesized to have triggered the pancreatitis.
- Pancreatic enzymes likely caused the pseudoaneurysm and subsequent pseudocyst formation.
- Computed tomography (CT) diagnosed the vascular complication, avoiding invasive angiography.
Implications:
- Conservative management of the pseudoaneurysm led to full recovery.
- This case highlights a potential link between multiple myeloma therapy and pancreatitis.
- Non-invasive diagnosis and conservative treatment are crucial for managing such rare complications.
Related Concept Videos
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction
Acute Pancreatitis II: Clinical Manifestations and Management